Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,669   2.87  Index Moved Up 0.17%
A0F5UH A0F5UHDE ISPA ETL5 Heavy Metals Marketing Education Conglomerates 
United States GSPC USD ...  |  Optimize Portfolios


Processing
Collecting data for WAG and BMY ...

Asset Comparison and Correlation

    
Investment horizon: 
  30 Days    Login   to change
 
 Walgreen Co.  vs   BristolMyers Squibb Company
 Compare Fundamentals  
Daily Returns (%)
BMY   WAG   
 
Considering 30-days investment horizon, Walgreen is expected to generate 5.5 times less return on investment than BristolMyers. But when comparing it to its historical volatility, Walgreen Co is 1.44 times less risky than BristolMyers. It trades about 0.03 of its potential returns per unit of risk. BristolMyers Squibb Company is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  4,230  in BristolMyers Squibb Company on April 22, 2013 and sell it today you would earn a total of  146.00  from holding BristolMyers Squibb Company or generate 3.45% return on investment over 30 days.

Diversification

Weak diversification
Overlapping area represents amount of risk that can be diversified away by holding Walgreen Co. and BristolMyers Squibb Company in the same portfolio assuming nothing else is changed

Correlation Coefficient

0.31
Parameters
Time Period1 Month [change]
DirectionPositive BMY Moved Up vs WAG
StrengthVery Weak
Accuracy95.45%
ValuesDaily Returns
Follow Correlation between WAG and BMY with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Correlation between WAG and BMY to your reader
 
Share Correlation between WAG and BMY 
Find Opportunities
 
Predicted Return Density
 
Returns   
BMY   WAG   

Walgreen Co

 
    
Walgreen
Performance
1
Out Of
100
Over 30
Days
99% of all equities and portfolios perform better than Walgreen Co. Compared with the overall equity markets, risk-adjusted returns on investments in Walgreen Co are ranked lower than 1 (%) of all global equities and portfolios over the last 30 days.
    

Match ups for Walgreen

CVS Caremark Corporation vs. Walgreen Co
GNC Holdings Inc vs. Walgreen Co
Rite Aid Corporation vs. Walgreen Co
PharMerica Corporation vs. Walgreen Co
China Nepstar Chain Drugstore Ltd vs. Walgreen Co
Liberator Medical Holdings Inc vs. Walgreen Co
Progressive Care Inc vs. Walgreen Co
Decision Diagnostics Corp vs. Walgreen Co
  

BristolMyers Squibb Company

 
    
BristolMyers
Performance
6
Out Of
100
Over 30
Days
94% of all equities and portfolios perform better than BristolMyers Squibb Company. Compared with the overall equity markets, risk-adjusted returns on investments in BristolMyers Squibb Company are ranked lower than 6 (%) of all global equities and portfolios over the last 30 days.
    

Match ups for BristolMyers

Johnson Johnson vs. BristolMyers Squibb Company
Pfizer Inc vs. BristolMyers Squibb Company
Novartis AG vs. BristolMyers Squibb Company
Sanofi vs. BristolMyers Squibb Company
Merck Co Inc vs. BristolMyers Squibb Company
GlaxoSmithKline plc vs. BristolMyers Squibb Company
AstraZeneca PLC vs. BristolMyers Squibb Company
Eli Lilly and Company vs. BristolMyers Squibb Company
Impax Laboratories Inc vs. BristolMyers Squibb Company


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium